Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 219 Neoplasms 15 Neoplasm Metastasis 12 Carcinoma, Intraductal, Noninfiltrating 10 Breast Neoplasms, Male 7 Breast Diseases 7 Breast Carcinoma In Situ 7 Advanced Breast Cancer 6 Triple Negative Breast Neoplasms 5 Ovarian Neoplasms 5 Endometrial Neoplasms 5 Neoplasms by Site 3 Breast Cancer Metastatic 3 Uterine Cervical Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasm Female 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Skin Diseases 1 Sexual Dysfunctions, Psychological 1 Sexual Dysfunction, Physiological 1 Seizures 1 Sarcoma 1 Recurrence 1 Quality of Life 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Osteoporosis 1 Multiple Endocrine Neoplasia Type 1 1 Low Grade Serous Ovarian Cancer 1

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × HER2 Negative Breast Cancer × Anastrozole × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡